Skip to content
healthcare.dev

Optimel Manuka Forte Eye Gel

NDC 73024-429, Glycerin, gel, from Melcare Biomedical Pty Ltd.

Product NDC
73024-429
Status
Listed
Labeler
Melcare Biomedical Pty Ltd
Dosage form
GEL
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M014
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73024-429 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCERIN2 mg/mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
73024-429-10730240429101 BOTTLE, DROPPER in 1 CARTON (73024-429-10) / 10 mL in 1 BOTTLE, DROPPER

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 73024-429 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73024-429 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73024-429. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.